The recent executive order issued by the Trump administration terminating federal programs promoting diversity, equity, and inclusion has sent shockwaves through the scientific community. One such program affected is the Cultural and Academic Research Experience (CARE) at Northern Arizona University, led by associate professor Naomi Lee. The abrupt termination of the NIH contract supporting CARE, which provided essential support to underrepresented students in the fields of science and medicine, has left Lee and her team reeling.
The impact of these cuts extends beyond just one program. Health equity researchers, racial justice advocates, and scientists across the country are grappling with the implications of the administration’s swift actions. The lack of clarity surrounding the definition of DEIA (diversity, equity, inclusion, and accessibility) in the executive order has left many wondering about the future of their work. Will efforts to address health disparities, improve outcomes for marginalized communities, and promote equal opportunity be jeopardized?
The uncertainty surrounding federal funding for health equity research has left many researchers on edge. With the freeze on public communication through Feb. 1, vital information on grant programs has disappeared from NIH web pages, leaving researchers in the dark. The potential loss of billions of dollars in federal funding could have far-reaching consequences, impacting not just researchers but also university employees and marginalized populations who rely on their work.
As the scientific community grapples with the fallout of the executive order, the importance of diversity in research is being underscored. Efforts to recruit underrepresented groups into clinical trials, such as those studying precision medicine and genomics, are crucial for advancing scientific understanding and improving health outcomes for all. The removal of material on clinical trial diversity from the FDA’s website has raised concerns about the future of inclusive research practices.
Despite the challenges posed by the executive order, leaders in the field of health equity remain resolute. Calls for perseverance, action, and advocacy are growing louder as researchers prepare to navigate an uncertain future. Lisa Cooper of the Johns Hopkins Center for Health Equity urges her colleagues to stay the course and continue the fight for justice and equality in healthcare.
As the dust settles on the aftermath of the executive order, researchers like Naomi Lee are left to pick up the pieces. While the loss of NIH funding will pose challenges for the CARE program, Lee remains determined to press on. With support from partner organizations and a commitment to continue the program’s essential work, Lee is focused on ensuring that her students and staff are not left behind in the wake of these sweeping changes.
